These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35133689)

  • 1. Proactive therapy: New perspectives for long-term topical treatment of psoriasis.
    Lis-Święty A; Frątczak A
    Dermatol Ther; 2022 May; 35(5):e15364. PubMed ID: 35133689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review and practical guidance on the use of topical calcipotriol and topical calcipotriol with betamethasone dipropionate as long-term therapy for mild-to-moderate plaque psoriasis.
    Zhao Y; Asahina A; Asawanonda P; Frez ML; Imafuku S; Hyun Kim D; Theng C; Wang L; Zhang JA; Zimmo S
    J Dermatol; 2021 Jul; 48(7):940-960. PubMed ID: 34036631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proactive Topical Maintenance Treatment of Psoriasis: Subanalysis of Canadian Patients in the Phase III PSO-LONG Trial.
    Hong HC; Adam DN; Rivers JK; Wiseman MC; Thoning H; McCracken CB
    J Cutan Med Surg; 2023; 27(1):63-64. PubMed ID: 36437761
    [No Abstract]   [Full Text] [Related]  

  • 4. Update on Topical Treatments for Psoriasis: The Role of Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam.
    Puig L; Carretero G
    Actas Dermosifiliogr (Engl Ed); 2019 Mar; 110(2):115-123. PubMed ID: 30031488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris of the trunk, limbs and scalp.
    McCormack PL
    Drugs; 2011 Apr; 71(6):709-30. PubMed ID: 21504248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PSO-LONG: Design of a Novel, 12-Month Clinical Trial of Topical, Proactive Maintenance with Twice-Weekly Cal/BD Foam in Psoriasis.
    Stein Gold L; Alonso-Llamazares J; Lacour JP; Warren RB; Tyring SK; Kircik L; Yamauchi P; Lebwohl M;
    Adv Ther; 2020 Nov; 37(11):4730-4753. PubMed ID: 32965655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twice-weekly topical calcipotriene/betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial).
    Lebwohl M; Kircik L; Lacour JP; Liljedahl M; Lynde C; Mørch MH; Papp KA; Perrot JL; Gold LS; Takhar A; Thaçi D; Warren RB; Wollenberg A
    J Am Acad Dermatol; 2021 May; 84(5):1269-1277. PubMed ID: 32950546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcipotriol/betamethasone dipropionate aerosol foam in the treatment of psoriasis: new perspectives for the use of an innovative topical treatment from real-life experience.
    Fabbrocini G; Dauden E; Jalili A; Bewley A
    G Ital Dermatol Venereol; 2020 Apr; 155(2):212-219. PubMed ID: 32394674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcipotriol/Betamethasone Dipropionate Foam: A Review in Plaque Psoriasis.
    Kim ES; Frampton JE
    Drugs; 2016 Oct; 76(15):1485-1492. PubMed ID: 27663245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical calcipotriol/betamethasone dipropionate for psoriasis vulgaris: A systematic review.
    Yan R; Jiang S; Wu Y; Gao XH; Chen HD
    Indian J Dermatol Venereol Leprol; 2016; 82(2):135-44. PubMed ID: 26924402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic literature review of long-term efficacy data for topical psoriasis treatments.
    Bark C; Brown C; Svangren P
    J Dermatolog Treat; 2022 Jun; 33(4):2118-2128. PubMed ID: 33945378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical calcipotriol plus betamethasone dipropionate for the treatment of plaque psoriasis: a drug evaluation.
    Purvis CG; Balogh EA; Heron CE; Feldman SR
    Expert Opin Pharmacother; 2021 Jun; 22(9):1107-1118. PubMed ID: 33745399
    [No Abstract]   [Full Text] [Related]  

  • 13. Calcipotriol/betamethasone dipropionate formulations for psoriasis: an overview of the options and efficacy data.
    Megna M; Cinelli E; Camela E; Fabbrocini G
    Expert Rev Clin Immunol; 2020 Jun; 16(6):599-620. PubMed ID: 32476507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a fixed combination of calcipotriol/betamethasone dipropionate topical gel in adult patients with mild to moderate psoriasis: blinded interim analysis of a phase IV, multicenter, randomized, controlled, prospective study.
    Reich K; Zschocke I; Bachelez H; de Jong EM; Gisondi P; Puig L; Warren RB; Mrowietz U;
    J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1156-63. PubMed ID: 25346093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term proactive management of psoriasis with calcipotriol and betamethasone dipropionate foam: an Italian consensus through a combined nominal group technique and Delphi approach.
    De Simone C; Dapavo P; Malagoli P; Martella A; Campanati A; Campione E; Errichetti E; Franchi C; Gambardella A; Megna M; Osti F; Ribero S; Zagni G; Calzavara-Pinton P; Fabbrocini G; ; Amoruso GF; Baglieri F; Biamonte AS; Bianchelli T; Bigi L; Bortoli J; Brunetti B; Buligan C; Cagni E; Calderoni O; Calzavara-Pinton P; Campanati A; Caputo A; Carrera CG; Carugno A; Chersi K; Cicchelli S; De Natale F; De Simone C; Dapavo P; Di Maria D; Errichetti E; Fabbrocini G; Ferrari AS; Fogli E; Forconi R; Franchi C; Galeazzi A; Gambardella A; Giovannini A; Giura MT; Iuculano M; Lazzaretti G; Leporati C; Magnanini M; Malagoli P; Marconi B; Martella A; Maruccia A; Megna M; Miglietta R; Minuti A; Mocci L; Modica S; Narcisi A; Odorici G; Osti F; Pazzaglia M; Peila R; Pertusi G; Pezza M; Pezzullo E; Puccia N; Raulo U; Ribero S; Rossi M; Rusignuolo S; Sapienza G; Savarese C; Scalisi M; Strippoli D; Stroppiana E; Tiberio R; Trischitta A; Tucci MG; Vaira F; Verrone A; Villa L; Zagni F; Zoccali A
    Int J Dermatol; 2022 Dec; 61(12):1543-1551. PubMed ID: 35609147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addressing challenges associated with long-term topical treatment and benefits of proactive management in patients with psoriasis.
    Lebwohl M; Thaçi D; Warren RB
    J Eur Acad Dermatol Venereol; 2021 Feb; 35 Suppl 1(Suppl 1):35-41. PubMed ID: 33619776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcipotriol/betamethasone ointment compared to narrow-band UVB in plaque psoriasis: first clinical and ultrasonographic study.
    Polańska A; Gaura T; Bowszyc-Dmochowska M; Osmola-Mańkowska A; Olek-Hrab K; Adamski Z; Żaba R; Dańczak-Pazdrowska A
    Int J Dermatol; 2019 Jan; 58(1):108-113. PubMed ID: 30070356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expert recommendations: the use of the fixed combination calcipotriol and betamethasone dipropionate gel for the topical treatment of psoriasis.
    Daudén E; Bewley A; Lambert J; Girolomoni G; Cambazard F; Reich K
    J Eur Acad Dermatol Venereol; 2014 May; 28 Suppl 2():22-32. PubMed ID: 24684740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris.
    Fenton C; Plosker GL
    Am J Clin Dermatol; 2004; 5(6):463-78. PubMed ID: 15663344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spotlight on calcipotriene/betamethasone dipropionate in psoriasis vulgaris of the trunk, limbs, and scalp.
    McCormack PL
    Am J Clin Dermatol; 2011 Dec; 12(6):421-4. PubMed ID: 21967117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.